Answer Capsule
John Hancock is a good, but not universally superior, fit for high-risk life insurance applicants. Four of the seven platforms named John Hancock during the ranking stage, and it finished with an average listed rank of 5.75 and a best rank of 3. Its strongest use-case evidence is a diabetes-focused Aspire program, wellness-linked Vitality pricing, and ExpressTrack accelerated underwriting for qualifying applicants. The main limitation is that John Hancock remains a fully underwritten carrier: serious complications, multiple impairments, smoking, hazardous occupations, or adverse recent medical history can still produce higher premiums, postponement, or declination, and no independent source reviewed confirmed that John Hancock beats every competing carrier on price or approval odds.
Research Snapshot
| Field | Finding |
|---|---|
| Platform mentions in ranking stage | 4 of 7 platforms (anthropic, kimi, openai, perplexity) |
| Share of included platform responses | 57.1% |
| Average listed rank | 5.75 |
| Best listed rank | 3 (kimi) |
| Relevant product/model/plan | John Hancock individual term or permanent life insurance with optional Vitality PLUS; Aspire for eligible applicants living with diabetes; ExpressTrack where the applicant and product qualify |
| Overall use-case fit | Strong (1 platform); Good (4 platforms); Uncertain (2 platforms) — 7 platforms analyzed |
| Research date | 2026-09-22 |
Why John Hancock Qualified for This Study
Questions This Section Answers
- Is John Hancock a good choice for life insurance for high-risk applicants?
- Why did AI platforms rank John Hancock for high-risk life insurance instead of other carriers?
John Hancock qualified because four of the seven included platforms named it during ranking discovery, giving it a 57.1% platform share and an average listed rank of 5.75 (best rank 3). It cleared the study's two-mention minimum with room to spare.
The qualification rests on three documented threads. First, John Hancock publishes underwriting guidance that identifies diabetes complications, younger-onset Type 1 diabetes, and smoking as factors that can worsen risk classification, and states that underwriting considers overall health, medical history, and lifestyle [1]. Second, it markets a diabetes-focused Aspire program and wellness-linked Vitality products [1]. Third, it carries a publicly documented financial-strength rating: AM Best's December 12, 2025 disclosure lists John Hancock Life Insurance Company (U.S.A.) at A+ Superior with a stable outlook [4].
Independent reviewers reached similar conclusions. RiskQuoter lists John Hancock as a company that does well with high-risk underwriting for medical conditions and dangerous occupations [5], and describes exceptional underwriting for high-risk health conditions plus Aspire underwriting credits for diabetics [6]. Pinney Insurance's underwriting guide describes competitive underwriting evaluations for conditions such as CAD, diabetes, and cancer [7].
Qualification is not the same as superiority. One platform (deepseek) could not verify several ranking-stage product names on the pages it checked and rated fit as uncertain [8]. Another (kimi) found no independent 2026 reviews of John Hancock's impaired-risk underwriting outcomes [9]. Buyers should treat John Hancock as one serious candidate in a multi-carrier comparison, not an automatic winner.
The Product, Model, Plan, or Service Most Relevant to Life Insurance for High-Risk Applicants
Questions This Section Answers
- Which John Hancock product should a high-risk applicant choose if they have Type 1 or Type 2 diabetes?
- Is John Hancock ExpressTrack available to high-risk applicants, or only to favorable health profiles?
- Does John Hancock offer simplified-issue or guaranteed-issue coverage for applicants who cannot qualify for full underwriting?
The most relevant John Hancock offering for this use case is individual term or permanent life insurance paired with the Aspire program for eligible applicants living with diabetes, optional Vitality PLUS, and ExpressTrack accelerated underwriting where the applicant and product qualify.
Aspire is designed for people living with Type 1 or Type 2 diabetes and is delivered through an eligible John Hancock life insurance policy with the Vitality benefit; eligibility, benefits, and availability vary by diabetes type, policy type, coverage amount, state, and program engagement [10]. John Hancock states Aspire can provide savings of up to 25% off the cost of insurance plus discounts on healthy foods [11], and offers virtual diabetes management through Onduo for Type 2 diabetes [12]. Aspire is not available in New York [10].
ExpressTrack lets qualifying applicants receive an underwriting decision without a traditional medical exam [14]. Independent reporting describes eligibility at ages 18–60 with single-life coverage up to $1M and a decision in about three days [15], while another review reports a 3–5 day issue timeline and notes that high-risk cases typically require standard medical underwriting with roughly a 30-day timeline [16]. One platform reports ExpressTrack available up to $3M for eligible risks at Standard or better, and states it excludes diabetes and many high-risk impairments [17]. These figures conflict and should be verified for the specific applicant.
Coverage ranges are broad: John Hancock publicly lists individual term coverage of approximately $250,000 to $30 million and permanent coverage of approximately $50,000 to $65 million, subject to underwriting, product, and state availability [18]. Independent reviews describe term and universal life but no traditional whole life product [19].
Simplified-issue availability is genuinely unclear. The ranking stage mentioned simplified-issue whole life, but the reviewed public John Hancock materials did not verify a currently available simplified-issue whole-life product with specific limits and underwriting rules. One platform found a simplified-issue term pathway with Vitality and return-of-premium features in partnership with Ethos, but public details on eligibility and underwriting depth are limited [21]. Another platform could not verify any simplified-issue whole life product on the pages it checked [22]. Buyers who need guaranteed acceptance should look elsewhere; no platform verified a John Hancock guaranteed-issue product.
What the AI Platforms Agreed About
Questions This Section Answers
- What do AI platforms agree John Hancock offers high-risk life insurance applicants?
- Is John Hancock's diabetes underwriting program a real advantage for high-risk applicants?
Agreement was strong, though not unanimous, on four points.
Diabetes is the clearest strength. Five platforms independently identified Aspire or diabetes-focused underwriting as John Hancock's strongest high-risk credential [23]. One independent source reports that 90% of diabetic applicants qualified for John Hancock over an 18-month period, with 88% receiving standard or better rates [28]. That figure is company-partnership reporting, not an independently audited outcome study.
Financial strength is well documented. AM Best lists John Hancock Life Insurance Company (U.S.A.) at A+ Superior with a stable outlook and financial-size category XV as of December 12, 2025 [29]. Independent reviews cite A+ (AM Best), Aa3 (Moody's), AA- (S&P), and AA (Fitch) [30]. Financial strength supports claims-paying confidence; it says nothing about whether an individual applicant will receive favorable underwriting.
Wellness-linked pricing is a real, priced feature. Vitality PLUS can be added to eligible policies. John Hancock states the fee may be as little as $2 per month, while its FAQ specifies 3% of annual premium for term policies with the optional rider, $2 per month for single-life permanent products, and $4 per month for survivorship policies [32]. Independent sources describe potential premium savings of up to 15–25% with engagement [34].
Underwriting is holistic, not lenient by default. Multiple platforms describe a whole-person or "Total View" underwriting approach that contextualizes multiple risk factors [23]. That is a company positioning claim, not independent evidence that John Hancock will produce a better offer than every competing carrier.
Where the AI Platforms Disagreed or Were Uncertain
Questions This Section Answers
- Why do some AI platforms rate John Hancock as uncertain for high-risk life insurance?
- Is John Hancock's simplified-issue whole life product actually available in 2026?
Platform fit ratings split: four platforms rated John Hancock "good," one rated it "strong," and two rated it "uncertain." The disagreements cluster around verifiability rather than substance.
Simplified-issue availability is unresolved. The ranking stage listed simplified-issue whole life, but the reviewed public materials did not verify a currently available John Hancock simplified-issue whole-life product with specific limits and underwriting rules. One platform could not verify it at all [37]; another found only a simplified-issue term pathway through Ethos with limited public detail [38].
ExpressTrack eligibility for high-risk applicants is contested. One platform states ExpressTrack is designed for favorable health profiles and that high-risk cases typically require standard medical underwriting [39]. Another states it excludes diabetes and many high-risk impairments [40]. A third reports no-exam eligibility for some applicants under age 60 and below a coverage threshold but notes John Hancock's own pages do not state a universal no-exam rule [41]. The available public material does not establish that ExpressTrack is broadly available to high-risk applicants or that it avoids medical-record review.
Pricing evidence conflicts. One source reports an average annual premium of $349, approximately 9% below the industry average of $382 [42]. Another reports John Hancock premiums 4.6% higher than the national average for 25-year-old rates [43]. The discrepancy may reflect 2026 rate reductions or differences in sample composition; buyers should request individual quotes.
Wellness discount magnitude varies by source. Some sources cite up to 25% premium savings; others cite 15% [44]. Actual savings depend on engagement level, policy type, Vitality status tier, and individual underwriting, and the calculation methodology is not transparent in available sources.
Product naming is inconsistent across official pages and third-party reviews. One platform could not verify "Aspire" or "Vitality Term" as current product names on the pages it checked [37]. Another notes product naming and feature packaging appear to differ across official pages and third-party reviews [46].
Public perception conflicts with financial strength. One platform reports John Hancock holds 1.3 of 5 stars on Trustpilot and is not BBB-accredited, creating a disconnect between claims-paying strength and perceived customer service experience [47]. This is platform-reported and not independently verified in the supplied research.
Use-Case-Specific Features and Capabilities
Questions This Section Answers
- What underwriting features make John Hancock competitive for applicants with diabetes or heart disease history?
- Does John Hancock offer non-tobacco rates to cigar, pipe, or chewing-tobacco users?
John Hancock's high-risk relevance rests on five capabilities, each with a qualifier.
Aspire diabetes program. Designed for Type 1 and Type 2 diabetes with underwriting credits, virtual coaching, and potential premium savings up to 25% [48]. Not available in New York [48]. One platform notes whether the program accommodates insulin-dependent or poorly controlled diabetes is not specified in accessible sources [52].
HealthyEdge crediting program. Replaced the retired HealthStyles program in 2018 and rewards preventative care and healthy habits with better risk classes [53]. Older literature still references HealthStyles, which is a stale-information risk buyers should be aware of.
Vitality wellness integration. All policies include Vitality GO at no cost, with optional Vitality PLUS from $2 per month enabling potential premium discounts [54]. Vitality PLUS is not available in New York [55]. Maximum savings require continuous tracking and sharing of personal activity data [56].
ExpressTrack accelerated underwriting. Qualifying applicants may receive a decision without a traditional medical exam [57]. Independent reporting describes a three-day decision for ages 18–60 up to $1M [58], while another source reports 3–5 days and notes high-risk cases still require full medical underwriting [59].
Alternative tobacco classification. John Hancock offers non-tobacco rates to applicants who use cigars, pipes, or chewing tobacco, provided they meet specific underwriting requirements [60]. This is a rarely available classification that benefits a segment often excluded or heavily rated.
AI-assisted preliminary underwriting. In January 2026, John Hancock launched a GenAI-powered Quick Quote tool designed for individuals up to age 75 and face amounts up to $10 million, reducing preliminary assessment turnaround from one day to 15 minutes [62]. This speeds agent-side assessment; it does not change final underwriting outcomes.
Pricing, Fees, Contracts, and Ongoing Costs
Questions This Section Answers
- How much does John Hancock Vitality PLUS cost per month, and does it vary by policy type?
- What fees and charges apply to John Hancock permanent life insurance for high-risk applicants?
No reliable public price can be stated for a high-risk applicant without age, coverage amount, policy type, state, medical history, and underwriting outcome. John Hancock's public materials provide product ranges and Vitality fees, not applicant-specific premiums [64].
Vitality PLUS pricing appears in multiple forms. The general Vitality page says the fee may be as little as $2 per month [65]. The FAQ gives product-specific formulas: 3% of annual premium for term policies with the optional rider, $2 per month for single-life permanent products, and $4 per month for survivorship policies [66]. One platform reports Vitality PLUS is included within the cost of Vitality Term and Simple Term with Vitality [67]. The applicable fee must be confirmed for the exact policy.
Permanent products carry additional cost layers. John Hancock product materials describe policy charges, cost-of-insurance charges, administrative charges, surrender charges, and policy-loan consequences [68]. Loans or withdrawals can reduce cash value and death benefits and may cause lapse or taxable income [69]. One platform notes withdrawals exceeding cost basis may be subject to ordinary income tax, with recapture tax within the first 15 years and a 10% federal penalty before age 59½ [70].
Contract terms vary by product. Term policies generally provide coverage for a stated period and may be convertible subject to the policy's eligibility and timing rules; permanent policies remain in force for life only if contractual requirements are satisfied [69]. One platform reports a typical 30-day free-look period and no pre-specified cancellation penalty in available documentation [70]. Exact conversion, grace-period, lapse, reinstatement, surrender, and rider terms must come from the policy contract and illustration.
Pricing confidence across platforms was moderate to low. Two platforms rated it moderate (openai, anthropic, grok), and two rated it low (deepseek, perplexity, kimi). Sample rates cited by platforms, such as approximately $9–$11 per month for a $100,000 20-year term for a 40-year-old nonsmoker, are for average health and are not indicative of high-risk pricing [70].
Best Suited For
Questions This Section Answers
- Who is John Hancock best suited for among high-risk life insurance applicants?
- Is John Hancock a good fit for a diabetic applicant who wants premium discounts through wellness engagement?
John Hancock is best suited for applicants with reasonably controlled Type 1 or Type 2 diabetes who can provide detailed medical information and are willing to engage with a wellness program [72].
It also fits applicants with family history of early heart disease who may qualify for preferred rates [73], applicants with clinical conditions such as CAD or cancer history who have favorable lifestyle offsets [75], and alternative tobacco users seeking non-tobacco rates [76].
Applicants seeking substantial coverage amounts from an established carrier are also a fit, subject to underwriting approval; term coverage runs approximately $250,000 to $30 million and permanent coverage approximately $50,000 to $65 million [77]. High-net-worth applicants with complex underwriting needs and large-case specialist support are another documented segment [78].
Finally, applicants who value wellness-linked rewards and premium adjustments and are comfortable working through a licensed agent fit the distribution model, since John Hancock does not offer direct consumer online enrollment [79].
Probably Not Best Suited For
Questions This Section Answers
- Who should not choose John Hancock for high-risk life insurance?
- Is John Hancock a poor fit for applicants who need guaranteed acceptance with no health questions?
Applicants seeking guaranteed acceptance or coverage without meaningful underwriting should not choose John Hancock. No platform verified a John Hancock guaranteed-issue product, and competitors such as Transamerica, Aflac, and Mutual of Omaha explicitly market these products with published waiting periods and graded benefits [80].
Applicants with severe or multiple medical impairments who need a carrier selected through broad multi-carrier underwriting are also a poor fit. One platform documents Transamerica as more flexible for paired conditions such as insulin-dependent diabetes with COPD or heart disease with stents, with no comparable evidence found for John Hancock [82].
Applicants who will not use wellness programs but are quoted a higher premium for Vitality-linked coverage should look elsewhere, since maximum savings require continuous tracking and data sharing [84]. New York residents seeking Aspire benefits are excluded, as the program is not available in New York [85].
Cost-sensitive buyers who want only inexpensive temporary protection and a competitor offers a better final term quote after full underwriting should compare offers. One platform reports smoker rates 31% higher than national average in some analyses [87]. Applicants seeking traditional whole life coverage should also look elsewhere, since John Hancock's permanent lineup is universal life, not whole life [88].
When Another Option May Be Better
Questions This Section Answers
- When is a different carrier a better choice than John Hancock for a high-risk applicant?
- What should a high-risk buyer do if John Hancock cannot confirm an eligible simplified-issue product?
Another carrier may be better when a competing carrier's informal underwriting review produces a better class or lower final premium for the applicant's specific diagnosis, medications, build, occupation, aviation, substance-use history, or criminal/financial risk factors [90].
Another option is likely better when the applicant needs guaranteed-issue or simplified-issue coverage and John Hancock cannot confirm an eligible product with acceptable limits and pricing. Competitors with published guaranteed-issue products include Transamerica, Aflac, Gerber Life, and Mutual of Omaha [91]. Transamerica Express Select is documented as a simplified-issue option with roughly eight health questions, $5,000–$100,000 coverage, and Premier/Select/Graded classes [92].
Another carrier may be better when the applicant wants no wellness-program fee, tracking, participation requirements, or changing rewards [93]. Applicants who need a highly specialized broker market for complex impairments, recent cancer, organ disease, severe psychiatric history, hazardous occupation, or multiple simultaneous risks should also compare specialists [90].
New York residents with diabetes need an alternative, since Aspire is unavailable there [90]. Applicants over age 80 needing term coverage are excluded by John Hancock's age limit and should look to carriers offering term to advanced ages [95]. Finally, buyers who want only inexpensive temporary protection should compare final term quotes after full underwriting [90].
Questions to Verify Before Buying
Questions This Section Answers
- What should a high-risk buyer confirm with John Hancock before signing a life insurance contract?
- How can a buyer verify John Hancock's underwriting class and Vitality fee before committing?
Which legal John Hancock insurer will issue the policy in the buyer's state, and what is that entity's financial-strength rating [96]?
For the buyer's exact diagnosis and history, what underwriting class is realistically expected, and which records, labs, attending-physician statements, or exams are required [98]?
Is Aspire available for the buyer's diabetes type, state, policy type, coverage amount, and proposed insurer [100]?
Does the proposed policy qualify for ExpressTrack, and can John Hancock still request medical records, labs, or an exam [102]?
What is the guaranteed premium schedule, and can premiums or cost-of-insurance charges change [104]?
What exact Vitality fee applies, what activities or data are required, and can rewards, discounts, or program terms change [105]?
Are there exclusions, contestability provisions, graded benefits, aviation or occupation restrictions, or other policy-specific limitations [100]?
What are the conversion deadline and available permanent products for the proposed term policy [107]?
For permanent coverage, what are guaranteed versus non-guaranteed values, surrender charges, policy-loan rates, and lapse risks under conservative assumptions [104]?
Has an independent broker compared the same fully disclosed case with multiple carriers before the buyer accepts the offer [100]?
Final AI Consensus Verdict
John Hancock is a good fit for many high-risk life insurance applicants, especially those with reasonably controlled diabetes or other non-preferred risks where its whole-person underwriting, Aspire program, Vitality features, or ExpressTrack may be relevant. Four of seven platforms rated fit as good, one as strong, and two as uncertain.
It should be treated as one serious candidate rather than an automatic best choice. High-risk buyers should obtain a confidential multi-carrier underwriting comparison and evaluate the actual offer, including ratings, fees, state availability, and permanent-policy guarantees. The strongest public evidence is company-provided; independent head-to-head underwriting evidence for high-risk applicants is limited, and no platform verified a John Hancock guaranteed-issue product.
How This Review Was Produced
This review synthesizes fit-research responses from seven AI platforms (anthropic, deepseek, google, grok, kimi, openai, perplexity) that evaluated John Hancock for the use case "Life Insurance for High-Risk Applicants." Four platforms named John Hancock during ranking discovery, meeting the study's two-mention minimum. Each platform supplied its own citations, which are labeled by platform and citation ID throughout this article.
Platform fit ratings were: anthropic good, deepseek uncertain, google good, grok strong, kimi uncertain, openai good, perplexity good. All included platforms evaluated fit; platform_mentions counts only platforms that named the entity during ranking discovery.
This is a fit review of John Hancock for one specific use case, not a broad company review. It is part of the broader Life Insurance for High-Risk Applicants consensus study, which compares multiple carriers across the same buyer scenario. Readers who want to compare carriers across the wider life insurance category can browse the full directory.
Methodology Limitations
Platform-reported research dates differ from the authoritative run date of 2026-09-22. Six platforms reported 2026-09-23; deepseek reported 2026-02-14. Platform-reported dates are provenance metadata and do not independently prove freshness.
One platform (deepseek) ran with search disabled, so its findings are model-reported rather than retrieved. Official-site retrieval failed for at least one mention; no failed fetch was used as a verified domain key, and the matching reported domain remains unverified.
Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. No-search model claims require explicit verification before being described as current facts.
Material conflicts remain unresolved: simplified-issue whole life availability, ExpressTrack eligibility for high-risk applicants, average premium comparisons ($349 versus 4.6% above national average), and wellness discount magnitude (15% versus 25%). Product naming and feature packaging differ across official pages and third-party reviews. Older literature still references the retired HealthStyles program, which was replaced by HealthyEdge in 2018.
Financial-strength ratings apply to the issuing legal insurer and should be matched to the legal insurer named in the proposed policy, especially where state-specific entities are involved. No platform verified a John Hancock guaranteed-issue product, and no independent source reviewed verified superior approval rates or lower premiums versus competing carriers.
Sources
Company-Owned Sources
- John Hancock: Homepage: https://www.johnhancock.com
- Life insurance designed for people living with diabetes: https://www.johnhancock.com/content/dam/fmg/USA/documents/life/brochure-aspire-consumer.pdf
- Risk class criteria: https://www.johnhancock.com/content/dam/mm/articles/life-9415_underwriting1.pdf
- Can I get life insurance if I have diabetes? | John Hancock: https://www.johnhancock.com/ideas-insights/can-i-get-life-insurance-if-i-have-diabetes.html
- 3 Myths About Getting Life Insurance While Having Diabetes: https://www.johnhancock.com/ideas-insights/top-myths-about-life-insurance-and-diabetes.html
- Life Insurance FAQs: Coverage, Claims & More: https://www.johnhancock.com/individual/help-center/life-insurance/frequently-asked-questions
- Can I get life insurance if I have diabetes?: https://www.johnhancock.com/individual/insights/finance-articles/can-i-get-life-insurance-if-i-have-diabetes
- Key Steps to Choose the Right Life Insurance Policy: https://www.johnhancock.com/individual/insights/finance-articles/choosing-right-life-insurance-policy
- The 4 Types of Permanent Life Insurance: https://www.johnhancock.com/individual/insights/finance-articles/types-of-permanent-life-insurance
- Life insurance: https://www.johnhancock.com/individual/life-insurance
- Permanent life insurance: https://www.johnhancock.com/individual/life-insurance/permanent-life-insurance
- John Hancock Vitality | Life Insurance: https://www.johnhancock.com/individual/life-insurance/vitality
- Life Insurance for Type 1 & 2 Diabetes | John Hancock: https://www.johnhancock.com/individual/life-insurance/vitality/aspire
- John Hancock Life Insurance: https://www.johnhancock.com/life-insurance.html
- John Hancock Aspire®: life insurance for people with diabetes: https://www.johnhancock.com/life-insurance/aspire.html
- Get the right life insurance policy for the protection you need - John Hancock: https://www.johnhancock.com/life-insurance/aspire/guide.html
- Permanent life insurance | John Hancock: https://www.johnhancock.com/life-insurance/permanent-life-insurance.html
- John Hancock Vitality: https://www.johnhancock.com/life-insurance/vitality.html
Additional AI research evidence108 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record perplexity:c2
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-2
- AI research evidence record anthropic:source-3
- AI research evidence record google:1.3.5
- AI research evidence record deepseek:c1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record openai:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.4
- AI research evidence record google:1.2.3
- AI research evidence record openai:c3
- AI research evidence record anthropic:source-12
- AI research evidence record anthropic:source-16
- AI research evidence record grok:17
- AI research evidence record openai:c4
- AI research evidence record anthropic:source-25
- AI research evidence record grok:18
- AI research evidence record perplexity:c6
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:source-3
- AI research evidence record grok:16
- AI research evidence record google:1.2.1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:source-26
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-31
- AI research evidence record grok:10
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record anthropic:source-27
- AI research evidence record grok:15
- AI research evidence record anthropic:source-6
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c6
- AI research evidence record anthropic:source-16
- AI research evidence record grok:17
- AI research evidence record perplexity:c8
- AI research evidence record anthropic:source-30
- AI research evidence record anthropic:source-36
- AI research evidence record anthropic:source-27
- AI research evidence record grok:15
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:source-1
- AI research evidence record openai:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.4
- AI research evidence record google:1.2.3
- AI research evidence record kimi:bestmoney-1
- AI research evidence record google:2.1.8
- AI research evidence record anthropic:source-19
- AI research evidence record anthropic:source-36
- AI research evidence record google:1.2.9
- AI research evidence record openai:c3
- AI research evidence record anthropic:source-12
- AI research evidence record anthropic:source-16
- AI research evidence record google:1.1.3
- AI research evidence record anthropic:source-21
- AI research evidence record google:2.2.3
- AI research evidence record google:2.2.5
- AI research evidence record openai:c8
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record perplexity:c5
- AI research evidence record openai:c10
- AI research evidence record openai:c9
- AI research evidence record anthropic:source-19
- AI research evidence record grok:10
- AI research evidence record openai:c1
- AI research evidence record anthropic:source-3
- AI research evidence record grok:16
- AI research evidence record google:1.3.5
- AI research evidence record google:1.1.3
- AI research evidence record openai:c4
- AI research evidence record anthropic:source-6
- AI research evidence record anthropic:source-1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record kimi:asurgo-guaranteed
- AI research evidence record kimi:asurgo-transamerica
- AI research evidence record kimi:asurgo-aflac
- AI research evidence record google:1.2.9
- AI research evidence record openai:c1
- AI research evidence record google:1.2.3
- AI research evidence record anthropic:source-36
- AI research evidence record anthropic:source-25
- AI research evidence record grok:18
- AI research evidence record openai:c1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record kimi:asurgo-transamerica
- AI research evidence record google:1.2.9
- AI research evidence record google:1.2.3
- AI research evidence record anthropic:source-29
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-31
- AI research evidence record openai:c2
- AI research evidence record anthropic:source-4
- AI research evidence record openai:c1
- AI research evidence record google:1.2.3
- AI research evidence record openai:c3
- AI research evidence record perplexity:c8
- AI research evidence record openai:c10
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record openai:c9
- AI research evidence record kimi:bestmoney-1
Independent Sources
- Aflac Final Expense Review 2026 - Rates by Age: https://asurgo.com/insurance-reviews/aflac
- Transamerica Life Insurance Review (2026): Real Rates & Costs: https://asurgo.com/insurance-reviews/transamerica
- Guaranteed Acceptance Life Insurance: https://asurgo.com/life-insurance/final-expense/guaranteed-acceptance/
- John Hancock Insurance Introduces John Hancock ExpressTrack™ to Significantly Accelerate and Simplify the Life Insurance Purchasing Process: https://coverager.com/john-hancock-insurance-introduces-john-hancock-expresstrack-significantly-accelerate-simplify-life-insurance-purchasing-process/
- John Hancock Launches GenAI-Based Tool to Accelerate Preliminary Underwriting: https://iireporter.com/john-hancock-launches-genai-based-tool-to-accelerate-preliminary-underwriting
- High-Risk Life Insurance — Coverage Options & Best Companies (2026: https://mozdex.com/life-insurance-for-high-risk/
- John Hancock No Exam Life Insurance (Up To $3,000,000!: https://nophysicaltermlife.com/john-hancock/
- Agent and Broker Companion (ABC) Guide Your guide to underwriting impairments: https://pinneyinsurance.com/images/underwriting/JohnHancock.pdf
- John Hancock Life Insurance Review (2026): Is It Worth It, and What's the Catch? - Rates Chaser: https://rateschaser.com/life-insurance/reviews/john-hancock-life-insurance-review/
- A. M. Best Company - AMB Rating Disclosure Report: https://ratings.ambest.com/DisclosurePDF.aspx?AMBNum=6681
- High-Risk Life Insurance: Options & Costs: https://www.bestmoney.com/life-insurance/learn-more/life-insurance-for-high-risk-individuals
- John Hancock and One Drop Partner to Empower People Living with Diabetes to Improve Their Health and Financial Wellness: https://www.biospace.com/john-hancock-and-one-drop-partner-to-empower-people-living-with-diabetes-to-improve-their-health-and-financial-wellness
- John Hancock Life Insurance Review 2025: https://www.businessinsider.com/personal-finance/life-insurance/john-hancock-life-insurance-review
- John Hancock Launches GenAI Tool to Speed Life Insurance Underwriting: https://www.cdomagazine.tech/artificial-intelligence/john-hancock-launches-genai-tool-to-speed-life-insurance-underwriting
- Is John Hancock a Good Insurance Company | Compare Rates: https://www.diversifiedquotes.com/is-john-hancock-a-good-insurance-company/
- John Hancock Life Insurance Review (2026): Pros and Cons: https://www.ethos.com/life-insurance/john-hancock-life-insurance-review/
- John Hancock life insurance ratings and review 2026 | Insure.com: https://www.insure.com/companies/john-hancock-life-insurance.html
- Life Insurance for High-Risk Applicants - Consumer Guidance: https://www.investopedia.com/best-life-insurance-for-high-risk-applicants-5186185
- Compare the Best Life Insurance for People With Diabetes in 2026: https://www.investopedia.com/the-best-life-insurance-for-diabetics-8780621
- John Hancock Life Insurance Review | 2026: https://www.marketwatch.com/insurance-services/life-insurance/john-hancock-life-insurance-review/
- 3 Best Life Insurance Companies for Diabetics in 2026: https://www.marketwatch.com/insurance-services/life-insurance/life-insurance-for-diabetics/
- John Hancock Life Insurance Review 2026: Pricing, Pros & Cons: https://www.moneygeek.com/insurance/life/reviews/john-hancock/
- John Hancock Life Insurance 2026: https://www.nerdwallet.com/insurance/life/john-hancock-life-insurance-review
- February 2018 Carrier Updates - Pinney Insurance: https://www.pinneyinsurance.com/assets/carrier-updates/john-hancock/healthyedge-upgrade-program.pdf
- Your guide to underwriting impairments. - Pinney Insurance: https://www.pinneyinsurance.com/assets/carrier-updates/john-hancock/john-hancock-abc-underwriting-guide.pdf
- John Hancock Insurance Introduces John Hancock ExpressTrack™ to Significantly Accelerate and Simplify the Life Insurance Purchasing Process: https://www.prnewswire.com/news-releases/john-hancock-insurance-introduces-john-hancock-expresstrack-to-significantly-accelerate-and-simplify-the-life-insurance-purchasing-process-300472999.html
- John Hancock Review: Policies, Underwriting & Vitality Program - RiskQuoter.com: https://www.riskquoter.com/company-reviews/john-hancock/
- High Risk Life Insurance: Coverage for Medical Conditions: https://www.riskquoter.com/high-risk-life-insurance/
- John Hancock Review: Policies, Underwriting & Vitality Program: https://www.riskquoter.com/john-hancock-life-insurance-review/
- John Hancock - Field Underwriting Guide: https://www.totalfinancial.com/carriers/downloads/johnhancock/uw/life-uw.pdf
- John Hancock Life Insurance Overview for 2026 | U.S. News: https://www.usnews.com/insurance/life-insurance/john-hancock
Additional AI research evidence108 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record perplexity:c2
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-2
- AI research evidence record anthropic:source-3
- AI research evidence record google:1.3.5
- AI research evidence record deepseek:c1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record openai:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.4
- AI research evidence record google:1.2.3
- AI research evidence record openai:c3
- AI research evidence record anthropic:source-12
- AI research evidence record anthropic:source-16
- AI research evidence record grok:17
- AI research evidence record openai:c4
- AI research evidence record anthropic:source-25
- AI research evidence record grok:18
- AI research evidence record perplexity:c6
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:source-3
- AI research evidence record grok:16
- AI research evidence record google:1.2.1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:source-26
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-31
- AI research evidence record grok:10
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record anthropic:source-27
- AI research evidence record grok:15
- AI research evidence record anthropic:source-6
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c6
- AI research evidence record anthropic:source-16
- AI research evidence record grok:17
- AI research evidence record perplexity:c8
- AI research evidence record anthropic:source-30
- AI research evidence record anthropic:source-36
- AI research evidence record anthropic:source-27
- AI research evidence record grok:15
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:source-1
- AI research evidence record openai:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.4
- AI research evidence record google:1.2.3
- AI research evidence record kimi:bestmoney-1
- AI research evidence record google:2.1.8
- AI research evidence record anthropic:source-19
- AI research evidence record anthropic:source-36
- AI research evidence record google:1.2.9
- AI research evidence record openai:c3
- AI research evidence record anthropic:source-12
- AI research evidence record anthropic:source-16
- AI research evidence record google:1.1.3
- AI research evidence record anthropic:source-21
- AI research evidence record google:2.2.3
- AI research evidence record google:2.2.5
- AI research evidence record openai:c8
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record perplexity:c5
- AI research evidence record openai:c10
- AI research evidence record openai:c9
- AI research evidence record anthropic:source-19
- AI research evidence record grok:10
- AI research evidence record openai:c1
- AI research evidence record anthropic:source-3
- AI research evidence record grok:16
- AI research evidence record google:1.3.5
- AI research evidence record google:1.1.3
- AI research evidence record openai:c4
- AI research evidence record anthropic:source-6
- AI research evidence record anthropic:source-1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record kimi:asurgo-guaranteed
- AI research evidence record kimi:asurgo-transamerica
- AI research evidence record kimi:asurgo-aflac
- AI research evidence record google:1.2.9
- AI research evidence record openai:c1
- AI research evidence record google:1.2.3
- AI research evidence record anthropic:source-36
- AI research evidence record anthropic:source-25
- AI research evidence record grok:18
- AI research evidence record openai:c1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record kimi:asurgo-transamerica
- AI research evidence record google:1.2.9
- AI research evidence record google:1.2.3
- AI research evidence record anthropic:source-29
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-31
- AI research evidence record openai:c2
- AI research evidence record anthropic:source-4
- AI research evidence record openai:c1
- AI research evidence record google:1.2.3
- AI research evidence record openai:c3
- AI research evidence record perplexity:c8
- AI research evidence record openai:c10
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record openai:c9
- AI research evidence record kimi:bestmoney-1
Other Sources
- Impaired Risk Life Insurance: What It Is & Who Needs It: https://www.ethos.com/life-insurance/impaired-risk-life-insurance/
Additional AI research evidence108 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record perplexity:c2
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-2
- AI research evidence record anthropic:source-3
- AI research evidence record google:1.3.5
- AI research evidence record deepseek:c1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record openai:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.4
- AI research evidence record google:1.2.3
- AI research evidence record openai:c3
- AI research evidence record anthropic:source-12
- AI research evidence record anthropic:source-16
- AI research evidence record grok:17
- AI research evidence record openai:c4
- AI research evidence record anthropic:source-25
- AI research evidence record grok:18
- AI research evidence record perplexity:c6
- AI research evidence record deepseek:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:source-3
- AI research evidence record grok:16
- AI research evidence record google:1.2.1
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:source-26
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-31
- AI research evidence record grok:10
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record anthropic:source-27
- AI research evidence record grok:15
- AI research evidence record anthropic:source-6
- AI research evidence record deepseek:c1
- AI research evidence record perplexity:c6
- AI research evidence record anthropic:source-16
- AI research evidence record grok:17
- AI research evidence record perplexity:c8
- AI research evidence record anthropic:source-30
- AI research evidence record anthropic:source-36
- AI research evidence record anthropic:source-27
- AI research evidence record grok:15
- AI research evidence record perplexity:c3
- AI research evidence record anthropic:source-1
- AI research evidence record openai:c1
- AI research evidence record google:1.2.1
- AI research evidence record google:1.2.4
- AI research evidence record google:1.2.3
- AI research evidence record kimi:bestmoney-1
- AI research evidence record google:2.1.8
- AI research evidence record anthropic:source-19
- AI research evidence record anthropic:source-36
- AI research evidence record google:1.2.9
- AI research evidence record openai:c3
- AI research evidence record anthropic:source-12
- AI research evidence record anthropic:source-16
- AI research evidence record google:1.1.3
- AI research evidence record anthropic:source-21
- AI research evidence record google:2.2.3
- AI research evidence record google:2.2.5
- AI research evidence record openai:c8
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record perplexity:c5
- AI research evidence record openai:c10
- AI research evidence record openai:c9
- AI research evidence record anthropic:source-19
- AI research evidence record grok:10
- AI research evidence record openai:c1
- AI research evidence record anthropic:source-3
- AI research evidence record grok:16
- AI research evidence record google:1.3.5
- AI research evidence record google:1.1.3
- AI research evidence record openai:c4
- AI research evidence record anthropic:source-6
- AI research evidence record anthropic:source-1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record kimi:asurgo-guaranteed
- AI research evidence record kimi:asurgo-transamerica
- AI research evidence record kimi:asurgo-aflac
- AI research evidence record google:1.2.9
- AI research evidence record openai:c1
- AI research evidence record google:1.2.3
- AI research evidence record anthropic:source-36
- AI research evidence record anthropic:source-25
- AI research evidence record grok:18
- AI research evidence record openai:c1
- AI research evidence record kimi:bestmoney-1
- AI research evidence record kimi:asurgo-transamerica
- AI research evidence record google:1.2.9
- AI research evidence record google:1.2.3
- AI research evidence record anthropic:source-29
- AI research evidence record openai:c5
- AI research evidence record anthropic:source-31
- AI research evidence record openai:c2
- AI research evidence record anthropic:source-4
- AI research evidence record openai:c1
- AI research evidence record google:1.2.3
- AI research evidence record openai:c3
- AI research evidence record perplexity:c8
- AI research evidence record openai:c10
- AI research evidence record openai:c6
- AI research evidence record openai:c7
- AI research evidence record openai:c9
- AI research evidence record kimi:bestmoney-1
Verify this research
Check when the research was run, which platforms were included, and what supports the findings.
- Study date
- September 22, 2026
- Platforms analyzed
- 7
- Source records
- 51
- Ranking mentions
- 4 of 7
- Platform share
- 57%
- Final consensus rank
- #7
Behind the findings
Platforms in this study
- ChatGPT
- Claude
- DeepSeek
- Grok
- Perplexity
- Kimi
- Gemini
Source records
31 independent · 19 company-owned · 1 unclear
Evidence support
31 direct · 4 partial
Keep in mind
Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.
Technical verification details
Use this SHA-256 fingerprint to identify the source snapshot associated with this study.
6d013928f875b3760b3bb4ba937372aa907bbee7d2a30633ea067fa2d6aa55b5